120
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Molecular docking, MMGBSA, and ADMET studies of phytoconstituents of Ocimum gratissimum on multiple breast cancer targets

, , , , , , , & ORCID Icon show all
Received 05 Mar 2024, Accepted 09 Apr 2024, Published online: 22 Apr 2024

References

  • Abdullah ML, Al-Shabanah O, Hassan ZK, Hafez MM. 2021. Eugenol-induced autophagy and apoptosis in breast cancer cells via PI3K/AKT/FOXO3a pathway inhibition. Int J Mol Sci. 22(17):9243. doi:10.3390/ijms22179243.
  • Ajiboye BO, Fagbola TM, Folorunso IM, Salami AW, Aletile ON, Akomolede BA, Ayemoni FI, Akinfemiwa KI, Anwo VO, Ojeleke MI, et al. 2023. In silico identification of chemical compounds in Spondias mombin targeting aldose reductase and glycogen synthase kinase 3β to abate diabetes mellitus. Inf Med Unlocked. 36:101126. doi:10.1016/j.imu.2022.101126.
  • Alven S, Aderibigbe BA. 2020. The therapeutic efficacy of dendrimer and micelle formulations for breast cancer treatment. Pharmaceutics. 12(12):1212. doi:10.3390/pharmaceutics12121212.
  • Anusmitha KM, Aruna M, Job JT, Narayanankutty A, Pb B, Rajagopal R, Alfarhan A, Barcelo D. 2021. Phytochemical analysis, antioxidant, anti-inflammatory, anti-genotoxic, and anticancer activities of different Ocimum plant extracts prepared by ultrasound-assisted method. Physiol Mol Plant Pathol. 117:101746. doi:10.1016/j.pmpp.2021.101746.
  • Anwar S, Shamsi A, Shahbaaz M, Queen A, Khan P, Hasan GM, Islam A, Alajmi MF, Hussain A, Ahmad F, et al. 2020. Rosmarinic acid exhibits anticancer effects via MARK4 inhibition. Sci Rep. 10(1):10300. doi:10.1038/s41598-020-65648-z.
  • Azhar MK, Anwar S, Hasan GM, Shamsi A, Islam A, Parvez S, Hassan MI. 2023. Comprehensive insights into biological roles of rosmarinic acid: implications in diabetes, cancer and neurodegenerative diseases. Nutrients. 15(19):4297. doi:10.3390/nu15194297.
  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68(6):394–424. doi:10.3322/caac.21492.
  • Bray F, Møller B. 2006. Predicting the future burden of cancer. Nat Rev Cancer. 6(1):63–74. doi:10.1038/nrc1781.
  • Caserta S, Genovese C, Cicero N, Toscano V, Gangemi S, Allegra A. 2023. The interplay between medical plants and gut microbiota in cancer. Nutrients. 15(15):3327. doi:10.3390/nu15153327.
  • Caserta S, Genovese C, Cicero N, Gangemi S, Allegra A. 2023. The anti-cancer effect of cinnamon aqueous extract: a focus on hematological malignancies. Life. 13(5):1176. doi:10.3390/life13051176.
  • Chen HM, Lee MJ, Kuo CY, Tsai PL, Liu J-Y, Kao S-H. 2011. Ocimum gratissimum aqueous extract induces apoptotic signalling in lung adenocarcinoma cell A549. Evid Based Complement Alternat Med. 2011:1–7. doi:10.1155/2011/739093.
  • Deshpande NS, Mahendra GS, Aggarwal NN, Gatphoh BFD, Revanasiddappa BC. 2021. In silico design, ADMET screening, MM‑GBSA binding free energy of novel 1,3,4 oxadiazoles linked Schiff bases as PARP‑1 inhibitors targeting breast cancer. Futur J Pharm Sci. 7(1):174. doi:10.1186/s43094-021-00321-4.
  • Dharsono HDA, Putri SA, Kurnia D, Dudi D, Satari MH. 2022. Ocimum species: a review on chemical constituents and antibacterial activity. Molecules. 27(19):6350. doi:10.3390/molecules27196350.
  • Di Salvo E, Gangemi S, Genovese C, Cicero N, Casciaro M. 2023. Polyphenols from Mediterranean plants: biological activities for skin photoprotection in atopic dermatitis, psoriasis, and chronic urticaria. Plants. 12(20):3579. doi:10.3390/plants12203579.
  • Fatoki TH, Awofisayo OA, Ibraheem O, Oyedele AS, Akinlolu OS. 2020. In silico investigation of first-pass effect on selected small molecule excipients and structural dynamics of P-glycoprotein. Bioinform Biol Insight. 14:1–9. doi:10.1177/11779322209431.
  • Fatoki T, Chukwuejim S, Ibraheem O, Oke C, Ejimadu B, Olaoye I, Oyegbenro O, Salami T, Basorun R, Oluwadare O, et al. 2022. Harmine and 7,8-dihydroxyflavone synergistically suitable for amyotrophic lateral sclerosis management: an insilico study. RRP. 8(3):49–61. doi:10.3897/rrpharmacology.8.83332.
  • Fatoki TH, Ibraheem O, Ogunyemi IO, Akinmoladun AC, Ugboko HU, Adeseko CA, Awofisayo OA, Olusegun SJ, Enibukun JM. 2021. Network analysis, sequence and structure dynamics of key proteins of coronavirus and human host, and molecular docking of selected phytochemicals of nine medicinal plants. J Biomol Struct Dynam. 39(16):6195–6217. doi:10.1080/07391102.2020.1794971.
  • Fatoki TH. 2023. Human adenovirus DNA polymerase is evolutionarily and functionally associated with human telomerase reverse transcriptase based on in silico molecular characterization that implicate abacavir and zidovudine. Front Bioinform. 3:1123307. doi:10.3389/fbinf.2023.1123307.
  • Friesner RA, Murphy RB, Repasky MP, Frye LL, Greenwood JR, Halgren TA, Sanschagrin PC, Mainz DT. 2006. Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein − ligand complexes. J Med Chem. 49(21):6177–6196. doi:10.1021/jm051256o.
  • Ganesan K, Xu B. 2017. Molecular targets of vitexin and isovitexin in cancer therapy: a critical review. Ann NY Acad Sci. 1401(1):102–113. doi:10.1111/nyas.13446.
  • Ghanbari-Movahed M, Shafiee S, Burcher JT, Lagoa R, Farzaei MH, Bishayee A. 2023. Anticancer potential of apigenin and isovitexin with focus on oncogenic metabolism in cancer stem cells. Metabolites. 13(3):404. doi:10.3390/metabo13030404.
  • Gyebi GA, Ogunyemi OM, Ibrahim IM, Afolabi SO, Ojo RJ, Ejike UDI, Adebayo JO. 2022. Inhibitory potentials of phytocompounds from Ocimum gratissimum against anti-apoptotic BCL-2 proteins associated with cancer: an integrated computational study. Egypt J Basic Appl Sci. 9(1):588–608. doi:10.1080/2314808X.2022.2106095.
  • Hart LR, Lebedenko CG, Mitchell SM, Daso RE, Banerjee IA. 2022. In silico studies of tumor targeted peptide-conjugated natural products for targeting over-expressed receptors in breast cancer cells using molecular docking, molecular dynamics and MMGBSA calculations. Appl. Sci. 12(1):515. doi:10.3390/app12010515.
  • Hasan MR, Alotaibi BS, Althafar ZM, Mujamammi AH, Jameela J. 2023. An update on the therapeutic anticancer potential of Ocimum sanctum L.: “elixir of life”. Molecules. 28(3):1193. doi:10.3390/molecules28031193.
  • Huang CC, Hwang JM, Tsai JH, Chen JH, Lin H, Lin GJ, Yang HL, Liu JY, Yang CY, Ye JC. 2020. Aqueous Ocimum gratissimum extract induces cell apoptosis in human hepatocellular carcinoma cells. Int J Med Sci. 17(3):338–346. doi:10.7150/ijms.39436.
  • Khojasteh-Poor F, Keivan M, Ramazii M, Ghaedrahmati F, Anbiyaiee A, Panahandeh S, Khoshnam SE, Farzaneh M. 2021. Mini review: the FDA-approved prescription drugs that target the MAPK signaling pathway in women with breast cancer. BD. 40(2):51–62. doi:10.3233/BD-201063.
  • Konstantinou EK, Panagiotopoulos AA, Argyri K, Panoutsopoulos GI, Dimitriou M, Gioxari A. 2023. Molecular pathways of rosmarinic acid anticancer activity in triple-negative breast cancer cells: a literature review. Nutrients. 1616 (1):2. doi:10.3390/nu16010002.
  • Laskar YB, Mazumder PB, Talukdar AD. 2023. Hibiscus sabdariffa anthocyanins are potential modulators of estrogen receptor alpha activity with favourable toxicology: a computational analysis using molecular docking, ADME/Tox prediction, 2D/3D QSAR and molecular dynamics simulation. J Biomol Struct Dyn. 41(2):611–633. doi:10.1080/07391102.2021.2009914.
  • Lim W, Park S, Bazer FW, Song G. 2016. Apigenin reduces survival of choriocarcinoma cells by inducing apoptosis via the PI3K/AKT and ERK1/2 MAPK pathways. J Cell Physiol. 231(12):2690–2699. doi:10.1002/jcp.25372.
  • Lin CC, Chao PY, Shen CY, Shu JJ, Yen SK, Huang CY, Liu JY. 2014. Novel target genes responsive to apoptotic activity by Ocimum gratissimum in human osteosarcoma cells. Am J Chin Med. 42(3):743–767. 42doi:10.1142/S0192415X14500487.
  • Messeha SS, Zarmouh NO, Asiri A, Soliman KFA. 2020. Rosmarinic acid-induced apoptosis and cell cycle arrest in triple-negative breast cancer cells. Eur J Pharmacol. 885:173419. doi:10.1016/j.ejphar.2020.173419.
  • Nangia-Makker P, Raz T, Tait L, Shekhar MPV, Li H, Balan V, Makker H, Fridman R, Maddipati K, Raz A. 2013. 2013. Ocimum gratissimum retards breast cancer growth and progression and is a natural inhibitor of matrix metalloproteases. Cancer Biol Ther. 14(5):417–427. doi:10.4161/cbt.23762.
  • Nassazi W, K’Owino IO, Makatiani J, Wachira S. 2020. Phytochemical composition, antioxidant and antiproliferative activities of African Basil (Ocimum gratissimum L.) leaves. AJACR. 6(4):1–18. doi:10.9734/ajacr/2020/v6i430166.
  • Nganteng DND, Melong R, Mbiekop EP, Maffo T, Allémann E, Delie F, Wafo P, Tchaleu BN, Dzoyem JP. 2022. Chemical constituents and cytotoxic activity of Ocimum gratissimum L. South Afr J Bot. 150:330–333. doi:10.1016/j.sajb.2022.07.029.
  • Njoku CJ, Zeng L, Asuzu IU, Oberlies NH, McLaughlin JL. 1997. Oleanolic acid, a bioactive component of the leaves of Ocimum gratissimum (Lamiaceae). Int J Pharmacog. 35(2):134–137. doi:10.1076/phbi.35.2.134.13290.
  • Okeleye BI, Okudoh VI, Ntwampe SKO. 2020. The role of microbial pathogens in cancer development: a potential guide to anticancer drugs. In: Chowdhary P, Raj A, Verma D, Akhter Y. Microorganisms for sustainable environment and health. Amsterdam: Elsevier. p. 469–492.
  • Ouyang X, Wei L, Pan Y, Huang S, Wang H, Begonia GB, Ekunwe SIN. 2013. Antioxidant properties and chemical constituents of ethanolic extract and its fractions of Ocimum gratissimum. Med Chem Res. 22(3):1124–1130. doi:10.1007/s00044-012-0113-z.
  • Prabhu KS, Lobo R, Shirwaikar AA, Shirwaikar A. 2009. Ocimum gratissimum: a review of its chemical, pharmacological and ethnomedicinal properties. Open Complement Med J. 1(1):1–15. doi:10.2174/1876391X00901010001.
  • Saini A, Kumar M, Bhatt S, Saini V, Malik A. 2020. Cancer causes and treatments. Int J Pharm Sci Res. 11(7):3121–3134.
  • Sitki-Copur M. 2019. State of cancer research around the globe. Oncol J. 33(5):181–185.
  • Sobantu MP, Okeleye BI, Okudoh VI, Meyer M, Aboua YG. 2023. In Vitro antioxidant mechanism of action of Hibiscus Sabdariffa in the induction of apoptosis against breast cancer. J Herbs, Spices & Med Plants. 29(3):213–228. doi:10.1080/10496475.2022.2135661.
  • Sun YS, Zhao Z, Yang ZN, Xu F, Lu HJ, Zhu ZY, Shi W, Jiang J, Yao PP, Zhu HP. 2017. Risk factors and preventions of breast cancer. Int J Biol Sci. 13(11):1387–1397. doi:10.7150/ijbs.21635.
  • Tibullo D, Caporarello N, Giallongo C, Anfuso C, Genovese C, Arlotta C, Puglisi F, Parrinello N, Bramanti V, Romano A, et al. 2016. Antiproliferative and antiangiogenic effects of Punica granatum Juice (PGJ) in Multiple Myeloma (MM). Nutrients. 8(10):611. doi:10.3390/nu8100611.
  • Ugbogu OC, Emmanuel O, Agi GO, Ibe C, Ekweogu CN, Ude VC, Uche ME, Nnanna RO, Ugbogu EA. 2021. A review on the traditional uses, phytochemistry, and pharmacological activities of clove basil (Ocimum gratissimum L.). Heliyon. 7(11):e08404. doi:10.1016/j.heliyon.2021.e08404.
  • Waks AG, Winer EP. 2019. Breast cancer treatment: a review. JAMA. 321(3):288–300. doi:10.1001/jama.2018.19323.
  • Xu Y, Jiang Z, Ji G, Liu J. 2010. Inhibition of bone metastasis from breast carcinoma by rosmarinic acid. Planta Med. 76(10):956–962. doi:10.1055/s-0029-1240893.
  • Yang J, Pi C, Wang G. 2018. Inhibition of PI3K/Akt/mTOR pathway by apigenin induces apoptosis and autophagy in hepatocellular carcinoma cells. Biomed. Pharmacother. 103:699–707. doi:10.1016/j.biopha.2018.04.072.
  • Zhu H, Zhao N, Jiang M. 2021. Isovitexin attenuates tumor growth in human colon cancer cells through the modulation of apoptosis and epithelial-mesenchymal transition via PI3K/Akt/mTOR signaling pathway. Biochem Cell Biol. 99(6):741–749. doi:10.1139/bcb-2021-004.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.